As announced in October, Attorney General Bridget Hill reminded Wyoming residents of the settlement agreement with Sanofi-Aventis U.S. LLC (Sanofi), which guarantees that Wyoming citizens not enrolled ...

Legal & General Assurance Society Limited (“Legal & General”) has completed a £1.4 billion buy-in with the Sanofi Pension Scheme (“the Scheme”), securing the benefits of 4,900 retirees and 5,600 ...

1990 - New pharma products introduced were TARIVID (a modern ... Georges, Director, Industrial Pharma Intercontinental of the sanofi-aventis Group and Mr. F. X. Duhalde, Director - Finance ...

It sells products through independent distributors ... the company came under the control of Sanofi-Synthelabo, now called sanofi-aventis which acquired indirect control 50.1% of the companys ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Increased menstrual blood loss can be hard to measure and may detract from a woman’s quality of life, but a range of ...

Sanofi India Limited (Previously known as Aventis Pharma Limited ... It has its own manufacturing facility at Goa. It sells products through independent distributors primarily in India.Sanofi India's ...

The mention of any product, service, or therapy in this Data Supplement should not be construed as an endorsement of the products mentioned ... AG (Inst), Pfizer (Inst), Pierre Fabre (Inst), Sanofi ...

Out of the entirety of a constellation shines brightest, the North Star. Likewise exist merely a handful of people; the cream of the crop, whose hard work, resilience, aspiration and grey matter ...

ShareThe year 2024 etched an indelible mark on Nigeria’s economic history as over 20 highprofile multinational corporations, including Unilever Nigeria Plc, Procter & Gamble, GlaxoSmithKline Consumer ...

Eric Le Berrigaud, an analyst from Stifel Nicolaus, maintained the Buy rating on Sanofi (SNYNF – Research Report). The associated price target ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.